Insight

Photo from The Institute of Cancer Research/LinkedIn

Sep 7, 2024, 15:31

Potential drug to target a rare childhood brain tumour – ICR

The Institute of Cancer Research (ICR) shared a post on LinkedIn:

“News: Research reveals a potential drug to target a rare childhood brain tumour.

ICR scientists and Dana-Farber Cancer Institute found a key weakness in the tumour cells which could be targeted by ribociclib, a drug already used to treat breast cancer.

Read more about the research, funded by The Brain Tumour Charity.”

Potential drug to target a rare childhood brain tumour - ICR

Source: The Institute of Cancer Research/LinkedIn

More posts featuring The Institute of Cancer Research on oncodaily.com

cancer childhood brain tumour Dana-Farber Cancer Institute ICR OncoDaily Oncology Ribociclib The Brain Tumour Charity The Institute of Cancer Research

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage